Epidemiology and clinical profile of vitiligo in Ibadan, Nigeria


  • Ehiaghe L. Anaba Department of Medicine, Lagos State University Teaching Hospital, Lagos, Nigeria
  • Adekunle O. George Department of Medicine, University College Hospital, Ibadan, Nigeria
  • Adebola O. Ogunbiyi Department of Medicine, University College Hospital, Ibadan, Nigeria




Clinical profile, Epidemiology, Nigeria, Vitiligo


Background: Vitiligo patients are seen routinely in the Dermatology Outpatient Clinic of the University College Hospital Ibadan, Nigeria. However, the epidemiologic and clinical profile of these patients is not documented. The aim of this study was to document the clinical (age of onset, location, severity, class of vitiligo) and sociodemographic characteristics of these patients.

Methods: This is a retrospective descriptive study of patients treated for vitiligo from January 2005 to December 2009 at the University College Hospital (UCH) Ibadan dermatology outpatient clinic. Patient records were retrieved and a study proforma was used to assess patient’s information. Data was analyzed using SPSS version 16.

Results: Over the study period, 130 vitiligo patients seen but only 111 case notes were retrieved. The mean age at onset in children was 7.8±4.0 and 34.6±17.1 in adults, M:F was 1:1. The commonest type of vitiligo was acrofacial, area of onset was the face/scalp in 59.2%, re-pigmentation was reported in 66%, active lesions in 59.7%, severity of vitiligo was <9% in 90%, Vitiligo was in visible (exposed) parts of the body 84.7% and asymptomatic in 92.7%.

Conclusions: The clinical profile of vitiligo in Ibadan, Nigeria is similar to that observed in other places with only females having a genital onset and acrofacial vitiligo being the dominant type seen. Also, treatment modality varies between children and adults.


Njoo MD, Westerhof W. Vitiligo: Pathogenesis and Treatment. Am J Clin Dermatol. 2001;2:167-81.

Firooz A, Bouzari N, Fallah N, Ghazisaidi B, Firoozabadi MR, Dowlati Y. What Patients with Vitiligo Believe About their Condition. Int J Dermatol. 2004;43:811-4.

Florez-Pollack S, Jia G, Zapata L Jr, Rodgers C, Hernandez K, Hynan LS, et al. Association of Quality of Life and Location of Lesions in Patients with Vitiligo. JAMA Dermatol. 2017;153:341-2.

Hedayat K, Karbakhsh M, Ghiasi M, Goodarzi A, Fakour Y, Akbari Z, et al. Quality of Life in Patients with Vitiligo: a Cross-sectional Study Based on Vitiligo Quality of Life index (VitiQoL). Health Quality of Life Outcomes. 2016;14:86.

Shah H, Mehta A, Astik B. Clinical and sociodermographic study of vitiligo in India. Indian J Dermatol Venereol Leprol. 2008;74:701-3.

Degboe B, Atadokpede F, Saka B, Adegbidi H, Koudoukpo C, Yedomon H, Ango-Padonou F. Vitiligo on Black Skin: Epidemiological and Clinical Aspects in Dermatology, Cotonou (Benin). Int J Dermatol. 2017;56:92-6.

Ayanlowo O, Olumide YM, Akinkugbe A, Ahamneze N, Otike-Odibi BI, Ekpudu VI, et al. Characteristics of Vitiligo in Lagos, Nigeria. West Afr J Med. 2009;28:118-21.

Lee H, Lee M, Lee DY, Kang HY, Kim KH, Choi GS, et al. Prevalence of Vitiligo and Associated Comorbidities in Korea. Yonsei Med J. 2015;56:719-25.

Akrem J, Baroudi A, Aichi T, Houch F, Hamdaoui MH. Profile of vitiligo in South of Tunisia. Int J Dermatol 2008;47:670-674.

Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al. Guideline for the diagnosis and management of vitiligo. Br. J Dermatol. 2008;159:1051-76.

Sehgal VN, Srivastava G. Vitiligo: compendum of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149-56.

Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the vitiligo European task force. Pigment Cell Res. 2008;20:27-35.

Nordlund JJ, L erner AB. Vitiligo: it is important. Arch Dermatol. 1982;118:5-8.

Statistical Package for Social Sciences (SPSS). Version 16.0 for Windows; Released 2006. Chicago: SPSS Inc. Available at: http://www.spss.en.softonic.com. Assessed 4 February 2011.

Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venerol. 2010;24:1144-50.

Choi S, Kim DY, Whang SH, Lee JH, Hann SK, Shin YJ. Quality of life and psychological adaptation of korean adolescents with vitiligo. J European Acad Dermatol Venereol. 2010;24:524-9.

Paravar T, Lee DJ. Vitiligo in an urban academic setting. Int. J Dermatol. 2010;49;39-43.

Parsad D, Handa S, Kanwar AJ. Late onset vitiligo: a study of 182 patients. Int J Dermatol. 2005;440:193-6.

Barros JC, Filho CD, Abreu LC, Barros JA, Paschoal FM, Nomura MT, et al. A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients. Int J Dermatol. 2014;53:842-8.

Onunu AN, Kubeyinje EP. Vitiligo in the Nigerian African: a study of 351 patients. Int J Dermatol. 2003;42:800-2.

Kiprono S, Chaula B. Clinical epidemiological profile of vitiligo. East Afr Med J. 2012;89:278-81.

Lin Z, Tian Y, Bai B, Liu M, Wu Y, Xiao B, et al. Comprehensive survey of vitiligo patients in the Northeast of CHINA using a predesigned questionnaire. J Dermatol. 2018;45:39-45.

Gonul M, Cakmak SK, Oguz D, Gul U, Kilic S. Profile of vitiligo patients attending a training and research hospital in central Anatolia: a retrospective study. J Dermatol. 2012;39:156-9.

Pradhan V, Patwardhan M, Thakkar V, Kharkar V, Khopkar U, Ghosh K, et al. Vitiligo patients from india (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries. J Eur Acad Dermatol Venerol. 2013;27:279-86.

Al-Mutari N, Sharma AK, Al-Sheltawy M, Nour-Eldin O. Childhood vitiligo: a prospective hospital-based study. Australian J Dermatol. 2005;46:150-5.

Pajvani U, Ahmad N, Wiley A, Levy RM, Kundu R, Mancim AJ, et al. The relatonship between family medical history and chilhood vitiligo. J Am Acad Dermatol. 2006;55:238-44.

Patil S, Gautam M, Nadkarni N, Saboo N, Godse K, Setia MS. Gender differences in clinicoepidemiological features of vitiligo: a cross-sectional analysis. ISRN Dermatol. 2014:6.

Schaffer JV, Bologna JL. The treatment of hypopigmentation in children. Clinics in Dermatol. 2003;21:296-310.

Falabella R, Barron MI. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res. 2008;22:42-65.

Radtke MA, Schafer I, Gajur AI, Augustin M. Clinical features and treatment outcomes of vitiligo from the patients’ perspective: results of a national survey in Germany. Dermatol. 2010;220:194-200.

Oguz TI, Duman H, Gungor S, Kocaturk E, Kuteyla CP. Evaluation of the clinical and sociodemographic features of Turkish patients with vitiligo. Acta Dermatovenerol Croat. 2016;24:124-9.




How to Cite

Anaba, E. L., George, A. O., & Ogunbiyi, A. O. (2018). Epidemiology and clinical profile of vitiligo in Ibadan, Nigeria. International Journal of Research in Medical Sciences, 6(12), 3801–3806. https://doi.org/10.18203/2320-6012.ijrms20184873



Original Research Articles